[The induction of nonspecific resistance by lysozyme and aristolochia acid in bacterial and viral infections].
D000818:Animals; D004195:Disease Models, Animal; D004357:Drug Synergism; D004686:Encephalomyocarditis virus; D005260:Female; D007274:Injections, Intraperitoneal; D007275:Injections, Intravenous; D007958:Leukocyte Count; D008297:Male; D051379:Mice; D009113:Muramidase / Q000627:therapeutic use*; D009975:Orthomyxoviridae; D009976:Orthomyxoviridae Infections / Q000097:blood / Q000401:mortality / Q000517:prevention & control*; D010587:Phagocytosis / Q000187:drug effects; D010616:Phenanthrenes / Q000627:therapeutic use*; D011051:Poliomyelitis / Q000401:mortality / Q000517:prevention & control*; D012481:Salmonella Infections, Animal / Q000401:mortality / Q000517:prevention & control*; D012486:Salmonella typhimurium; D013203:Staphylococcal Infections / Q000097:blood / Q000401:mortality / Q000517:prevention & control*; D013210:Staphylococcus / Q000187:drug effects
D010616:Phenanthrenes; D009113:Muramidase
Zur unspezifischen Schutzwirkung von Lysozym und Aristolochiasäure bei bakteriellen und viralen Infektionen.